India’s pharmaceutical industry is undergoing a strategic transformation from volume-led expansion to value-driven growth, according to the Economic Survey 2025-26. The report emphasizes rising focus on innovation, complex generics, specialty drugs and global contract manufacturing as key drivers of sustainable growth. Strengthening regulatory compliance, increased investment in research and development and expanding global market access are reshaping the sector’s long-term trajectory. The survey also highlights the industry’s critical role in healthcare security and export growth.